Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Other Operating Expenses (2016 - 2023)

Plus Therapeutics (PSTV) has disclosed Other Operating Expenses for 13 consecutive years, with $2.7 million as the latest value for Q4 2023.

  • Quarterly Other Operating Expenses rose 15005.56% to $2.7 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2024, up 16893.75% year-over-year, with the annual reading at -$66000.0 for FY2021, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2023 was $2.7 million at Plus Therapeutics, up from -$2000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $2.7 million in Q4 2023, with the low at -$305000.0 in Q4 2019.
  • Average Other Operating Expenses over 5 years is $388666.7, with a median of $94000.0 recorded in 2019.
  • The sharpest move saw Other Operating Expenses crashed 748.94% in 2019, then soared 15005.56% in 2023.
  • Over 5 years, Other Operating Expenses stood at -$305000.0 in 2019, then skyrocketed by 356.07% to $781000.0 in 2020, then tumbled by 102.3% to -$18000.0 in 2021, then soared by 200.0% to $18000.0 in 2022, then skyrocketed by 15005.56% to $2.7 million in 2023.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $2.7 million, -$2000.0, and $18000.0 for Q4 2023, Q1 2023, and Q4 2022 respectively.